Atlas Trials

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Velpatasvir in Participants With Chronic HCV Infection

Clinical trial NCT01740791 · COMPLETED

Trial details

NCT number
NCT01740791
Sponsor
Gilead Sciences
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Chronic Hepatitis C Virus
Start date
2012-11-06
Primary completion
2013-03-15
Enrollment
103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.